Chart Outlooks: BCLI, GRMC, IMSC

An undecided market continues to batter the bears and the bulls equally. As such, it still pays to keep more ideas than you can use on your radar, and it pays to make sure you've got ideas from both sides of the fence. With that in mind, let's examine Goldrich Mining Company (OTC:GRMC), Brainstorm Cell Therapeutics Inc. (NDA) (OTC:BCLI), and Implant Sciences Corporation (OTC:IMSC).

I think it's time to get ready for round three of bullishness from Implant Sciences Corporation (OTC:IMSC). With the exception of a couple of short-lived pops, the stock's been gravitating around the $0.33 are since late December. Today's 11% rally from IMSC, however, hints the bulls are testing the waters again.

To a small degree (very small), the recent rebound from IMSC can be attributed to a rising support line that can be traced back to pullback after the late-January peak. The second node of that line can be traced back to the pullback from the January peak. After hitting it a third time three sessions ago, Implant Sciences Corporation has finally established enough of a base that it can actually do something with the support.

As for a target, the last two surges Implant Sciences Corporation shares were on the order of $0.50 to $0.60 each (from the preceding low). So, this one could be comparable; that leaves at least $0.40 in front of IMSC at its current price. In the meantime though, getting above the near-term ceiling at $0.40 is critical. 

If you were hanging onto Goldrich Mining Company (OTC:GRMC) and hoping the last six months were just a little turbulence, then I've got bad news for you. If you were looking for a short trade idea, or looking for vindication that you got out of GRMC more than a few days ago, then I've got food news for you.

Not that it means a whole lot when a stock trades as thinly as it does for GRMC, but this chart has broken out of an important wedge formation.... bearishly. The fact that the break under support for Goldrich Mining Company came on a major volume day (the 3rd) is just icing on the cake.

I don't have a landing spot in mind for Goldrich Mining now that the selling has been put into motion. But, in light of the lower highs between August and now, I wouldn't assume that the low from October is going to act as support. GRMC may well revisit the $0.10 area again before it's all over.


Brainstorm Cell Therapeutics Inc. (NDA) (OTC:BCLI) has made good slow-n-steady progress over the last two months, and I think it's a stock you want to keep on your breakout watchlist. A little more in the way of gains could actually be a lot more for BCLI in terms of getting past a very precise technical hurdle.

The bout at $0.26 was no small feat for BCLI in December and January. That resistance line had also been a support level for the stock in October and November, and it wasn't clear if Brainstorm Cell Therapeutics was going to even be able to get back past that mark. Now that it has though, we can reasonable assume support will be found there in the future ... if needed.

The end result of that move is the return of Brainstorm Cell Therapeutics Inc. to its $0.26/$0.31 trading range. BCLI can tread in that zone as long as its wants, prepping for the breakout above the $0.31 ceiling. In fact, the longer it churns in that range, the stronger the breakout should be. Just keep it nearby.